A Study to Compare unani formulation Zimad-e-Roos and Diclofenac Gel Along with Physiotherapy in Patients with Frozen Shoulder

A Randomized Parallel Arm Controlled Clinical Trial to compare the Therapeutic Potentiality and Tolerability of Topical Zimad-e-Roos & Diclofenac gel 2% with Standard Physiotherapy in management of Adhesive Capsulitis of Shoulder Joint (Tahajjur-e-Mafasil-e-Katif) - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101073

Enrollment

Registered

2026-01-14

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: ZIMAAD-E-ROOS: Local Application- ZIMAAD-E-ROOS:Maghz-e-tukhum-e-Bed Anjeer(Ricinus communis L)-300g, Rogan-e-Gao(Clarified butter)-300g,Asal(honey)-100g as required(BD)Twice a day Alon

Eligibility

Inclusion criteria

Inclusion criteria: Age 30-60 years Both sexes. Unilateral or bilateral shoulder pain, stiffness, and limited mobility. Positive Apley Scratch Test and Coracoid Pain Test. PROM limitation in capsular pattern (ER more than Abd more than IR). Symptoms lasting more than 1 month, no radiological abnormalities. SPADI score 20-80. Cases without structural damage of joint (e.g., minor trauma, post-Surgery immobilization).

Exclusion criteria

Exclusion criteria: Systemic illnesses (e.g. unstable angina, CKD, Chronic liver diseases, epilepsy, Schizophrenia, Neurological disorders. History of major trauma, surgery, fracture, dislocation or rotatory cuff tears. Corticosteroid injections use in last 3 months. Pregnant and lactating women Non- consenting patients. Conditions like osteomyelitis, rheumatoid arthritis etc.

Design outcomes

Primary

Measure	Time frame
Improvement in quality of life- Shoulder pain and disability index scale (SPADI Score )Timepoint: 15th day-30th day-45th day	—

Secondary

Measure	Time frame
Improvement in AROM(goniometer Scale)Timepoint: 15th day-30th day-45th day	—

Countries

India

Contacts

Public ContactDr Sana

Government Nizamia Tibbi College and General Hospital

sakhussaini@gmail.com9704888561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026